about
Serum thymidine kinase 1 levels correlate with clinical characteristics of esophageal squamous cell carcinomaPhase II study of neoadjuvant therapy with nab-paclitaxel and cisplatin followed by surgery in patients with locally advanced esophageal squamous cell carcinomaEffect of Smac in combination with cisplatin on esophageal cancer cell line ECA109
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Multimodality management of esophageal cancer.
@ast
Multimodality management of esophageal cancer.
@en
Multimodality management of esophageal cancer.
@nl
type
label
Multimodality management of esophageal cancer.
@ast
Multimodality management of esophageal cancer.
@en
Multimodality management of esophageal cancer.
@nl
prefLabel
Multimodality management of esophageal cancer.
@ast
Multimodality management of esophageal cancer.
@en
Multimodality management of esophageal cancer.
@nl
P2093
P2860
P1476
Multimodality management of esophageal cancer.
@en
P2093
C S Pramesh
George Karimundackal
Pallavi Purwar
Sabita Jiwnani
Sarbani Ghosh Laskar
Supriya Bambarkar
P2860
P304
P356
10.1007/S12262-014-1163-X
P577
2014-09-11T00:00:00Z